Remimazolam in anesthesia and sedation: A narrative review
Authors:
- Yan DongYDYan Dong
- Jun MaJMJun Ma
Open Access
- 1 September 2025
- journal article
- Published by KEAI Publishing in Journal of Anesthesia and Translational Medicine
- Vol. 4 (3) , 142-147
Abstract
Remimazolam, an innovative sedative, provides a rapid onset and quick recovery by being rapidly hydrolyzed into pharmacologically inactive CNS7054 via ubiquitous nonspecific esterases. Its pharmacokinetic characteristics (high clearance rate, small steady-state volume of distribution, short terminal half-life, and no tissue accumulation) further lay the foundation for clinical application. Compared with traditional sedative drugs, the prominent innovations of this drug are reflected in three aspects: first, it has less impact on the respiratory and circulatory systems, with stable hemodynamics and a low incidence of discomfort at the administration site; second, its sedative effect can be specifically antagonized by flumazenil, allowing for more flexible safety regulation; third, it shows excellent safety and effectiveness in special populations such as elderly patients and those with comorbid cardiovascular diseases. Clinical evidence shows that remimazolam is more effective than similar drugs in scenarios such as gastrointestinal endoscopy, operating rooms, and ICUs. Its reliable performance in special populations further supports its value as a sedative that combines innovation with clinical practicality and holds broad application prospects. This review aims to systematically elaborate on the pharmacological properties and clinical application value of remimazolam, a new benzodiazepine derivative, and provide references for its standardized use in various diagnostic and therapeutic scenarios and special populations.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 60 references indexed in Scilit:
- Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer PatientsCurrent Oncology Reports, 2024
- Remimazolam for anesthesia and sedation in pediatric patients: a scoping reviewJournal of Anesthesia, 2024
- Remimazolam for cardiovascular anesthesiaJournal of Anesthesia, 2023
- Remimazolam Compared to Propofol During Hysteroscopy: A Safety and Efficacy AnalysisPain and Therapy, 2023
- Ringer's acetate solution-induced precipitation of remimazolamBritish Journal of Anaesthesia, 2021
- How to administer remimazolam for anesthesia inductionJournal of Anesthesia, 2020
- Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trialJournal of Anesthesia, 2020
- Time‐to‐Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General AnesthesiaThe Journal of Clinical Pharmacology, 2020
- Clinical Practice Guideline for Emergency Department Procedural Sedation With Propofol: 2018 UpdateAnnals of Emergency Medicine, 2019
- Effects of anesthetics on early postoperative cognitive outcome and intraoperative cerebral oxygen balance in patients undergoing lung surgery: a randomized clinical trialCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2016